Evidence 1
Activity
Activity
20% Hemolysis
Toxicity
100 µM
Hemolytic
Cytotoxic
20% Hemolysis | 100 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
NOVEL PEPTIDE AND USES THEREOF | Patent US 20160130301 A1 | 2016